Calibrating a network meta-analysis of trials of sodium glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population (2022)
Attributed to:
Real-world treatment effectiveness in people with type 2 diabetes: Maximising the applicability of clinical trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract